全球抗生物膜伤口敷料市场于2019年的575.4百万美元估价,预计预测期内的CAGR 9.2%。增加慢性疾病,即糖尿病,癌症,以及烧伤病例的增加,体育伤害,街道事故是负责市场增长的关键因素。Moreover, the patients with various disorders are increasing as due to COVID-19 such as the eating habits, sedentary, changes in lifestyle is affecting badly which is affecting at human’s health which leads to growth in chronic diseases such as cancer, diabetes which is fueling the global market.
此外,易感病原体的多药耐药性以及在发育新的抗微生物中缺乏成功导致了巨大的危机。抗生物膜是通过压制微生物粘连的机制来防止生物膜形成的天然基质,并防止通过ECM产生形成聚合物基质。这些药剂广泛用于敷料目的,因为它抑制了对最小化进一步感染有益的微生物污染。治疗伤口的主要临床挑战是伤口渗出物的管理和有效治疗生物膜相关感染。
Know more about this report:request for sample pages
Growth Drivers
Rising cases of burns, trauma, and road accidents globally is witnessed to fuel the global market. As per the World Health Organization (WHO) in 2018, around 1,000,000 individuals in India suffered from severe & moderate burn per year. Additionally, according to the NCBI, in 2017, countries i.e. Finland, Bulgaria, the Netherlands, South Korea, China, and the U.K. has recorded an increase in the cases of burn wounds.
Meanwhile, as per the American Association for the Surgery of Trauma (AAST), in 2017, more than 1.2 million people died worldwide, & by road mishaps more than 3,242 deaths every day. Road mishaps mostly occurred at middle or lower-income level countries. Biomaterials & skin ingredients are widely used in healing varied types of burn wounds. Hence, increasing accidental cases is estimated to propel the demand for these products, that is projected to lead to market growth.
Cancer is widely caused disorder which leads to death. As per the WHO, cancer is the main reason of mortality worldwide and around one in six deaths occurred owing to cancer. Additionally, more than 70 per cent of cancer-related deaths prevailed in middle and low income levels countries. Due to the increasing incidences of chronic disorders, the prolonged hospitalization is increasing along with surgeries which would increase the demand for anti-biofilm wound dressing treatment.
Moreover, as now people are actively participating in sports activities, hence the chances of injuries are also increasing. For example, as per the Stanford Children’s Health, approximately 3.5 million injuries are recorded each year among the pediatric population in the U.S., and approximately 21 per cent of the injuries are traumatic. Besides this, as per the Canadian Institute for Health Information (CIHI), in 2017, more than 17,655 individuals were hospitalized owing to sports regarding injuries. Thus, increasing cases of injuries are witnessed to fuel the demand for global market.
该市场主要基于机制模式,通过申请,最终用途和地理区域进行分段。
By Mode of Mechanism |
通过申请 |
通过最终使用 |
按地区 |
|
|
|
|
Know more about this report:request for sample pages
基于机制模式,全球市场分为物理,生物和化学品。同样,机制部门的化学模式在2019年举行了大幅份额。预计该部门将在研究期内目睹主要增长,因为全世界的慢性伤害案件案件增加。化学抗生物膜伤口敷料产品对生物膜有多项动作,从而提高了慢性伤口的愈合和回收率。它还最小化了两种类型的伤口的生物膜负担,随着与微生物进行再污染的风险。
基于应用程序,全球ti-biofilm wound dressing market is categorized into Chronic and Acute Wounds. It includes surgical wounds, minor cuts, bites, abrasions & burns, along with severe traumatic lacerations i.e. caused by gunshot injuries. On the other hand, the chronic wounds occurred by endogenous mechanisms owing to the predisposing condition i.e. dermal and epidermal tissue integrity. The chronic wounds are formed by the pressure sores, foot ulcers & leg ulcers, results by venous hypertension or impaired arterial supply and metabolic diseases including diabetes mellitus.
The acute wounds segment held the significant revenue share in 2019. It includes burns & wounds. The rise in the burn injuries cases globally are driving the growth of the segment. Each year, more than 50% of the populace worldwide is at the risk factor of fire-related traumas, of which 90% of the incidents occurred in moderate-to-lower level income countries. According to the World Health Organization, around 1,000,000 people are recorded moderately & severely burnt in every year. Moreover, the primary treatment involves the dressing and prevention of injury from the biofilm formation. Henceforth, the rising patients who are suffering from an acute injury are projected to fuel the segment growth.
基于最终使用,全球市场分为医院,伤口护理中心,诊所和其他市场。预计医院有望在预测期内目睹预测期内的显着增长率,由于慢性伤口和住院期间崛起的案件。此外,糖尿病脚和静脉腿部溃疡的上升案例是推动细分增长的关键因素。然而,由于手术的增加,外科伤口事件正在提高进一步推动细分的生长。
Based on the region, the global anti-biofilm wound dressing market has been categorized into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Among all, North America has dominated the market in 2019. The rising cases of the road accidents, sports related injuries, and presence of big players in this region are the factors which are fueling the regional market growth. Additionally, the presence of good healthcare facilities and suitable reimbursement policies also favoring the market.
In the Asia Pacific, the market is projected to achieve fastest growth at the forecasted period owing to the presence of various developing countries including China, Japan & India are witnessed to drive the regional market. Additionally, the expanding medical tourism industry in these regions is further contributing to concerned product demand. For example, as per the report of the Export Health Services by Directorate General of Commercial Intelligence & Statistics of India, in 2016, India had 58,300 medical tourists.
在拉丁美洲,市场目睹在规范期间以大幅增长成长。目睹了包括墨西哥和巴西在内的新兴经济体的存在,以提高区域市场增长。在拉丁美洲的降低成本下提前治疗选择的存在正在为医疗旅游制作合适的位置。此外,这些国家的政府介绍了改善医疗基础设施。yabo娱乐vip从此,所有这些因素都会预计促进该地区的市场增长。
Key players operating in the global market are concentrating on the joint ventures, collaborations, regional expansion and investments for fortifying their worldwide impressions by entering into undiscovered markets. Additionally, the companies are also focusing on the research and development to develop technologically advanced products to sustain in the competition.
Imbed Biosciences Inc. has been rewarded with a USD 1.5 million & National Institute for Arthritis grant for the research and development of the bioresorbable wound dressing incorporated with gallium & silver metal ions that is bactericidal in nature. This anti-biofilm dressing research program is built by the clinical success of Microlyte silver dressing to be utilized in the treatment of chronic wounds patients. Moreover, previously, in November 2017, The National Biofilms Innovation Centre (NBIC) has been funded with the EUR 12.5 million with the rationale of prevention, detection, & management of engineered biofilms. Some of the major players operating the global market include Urgo Medical, ConvaTec, Coloplast, Smith & Nephew PLC, 3M, Monarch Labs, Mega Pharma (Pvt) Ltd., BioMonde, B. Braun Melsungen AG, Mölnlycke Healthcare, Lohmann & Rauscher & Arobella Medical.